In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…
Read More
QIAGEN Digital Insights Partners with NVIDIA to Revolutionize AI-Driven Drug Discovery
The integration of NVIDIA’s accelerated computing and BioNeMo platform with QIAGEN Digital Insights’ bioinformatics capabilities is poised to usher in…
Read More
Groundbreaking Drug Screening Platform Developed to Combat Neurological and Psychiatric Diseases by Targeting Protein Expression Imbalances
A pioneering drug screening platform has been successfully developed by researchers, designed to identify compounds that directly address the fundamental…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
The Unapproved QUAD Cocktail: A Closer Look at its Composition QUAD is a compounded sublingual dose product marketed by MEDVi…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Unveils Groundbreaking Innovations from Early-Stage Biotechs, Reinforcing Global Drug Discovery Ecosystem
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
SLAS Europe 2026 Set to Unveil Transformative Innovations in Drug Discovery and Laboratory Automation in Vienna
The Society for Laboratory Automation and Screening (SLAS) 2026 European Conference and Exhibition is poised to converge in Vienna, Austria,…
Read More
Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development
AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…
Read More
Breakthrough in Bioengineering: First Fully Human Bone Marrow Model Replicated in Laboratory Setting to Transform Cancer Research and Drug Testing
In a landmark achievement for regenerative medicine and oncology, researchers from the University of Basel and University Hospital Basel have…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…
Read MoreYOU MAY HAVE MISSED
